American Express (AXP) Offering Possible 42.45% Return Over the Next 24 Calendar Days

American Express's most recent trend suggests a bullish bias. One trading opportunity on American Express is a Bull Put Spread using a strike $125.00 short put and a strike $120.00 long put offers a potential 42.45% return on risk over the next 24 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $125.00 by expiration. The full premium credit of $1.49 would be kept by the premium seller. The risk of $3.51 would be incurred if the stock dropped below the $120.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for American Express is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for American Express is bullish.

The RSI indicator is at 60.86 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for American Express

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of American Express Company – AXP
Sun, 24 Jan 2021 04:45:00 +0000
NEW YORK, NY / ACCESSWIRE / January 23, 2021 / Pomerantz LLP is investigating claims on behalf of investors of American Express Company (“American Express” or the “Company”) (NYSE:AXP). Such investors are advised to contact Robert S.

AmEx (AXP) to Report Q4 Earnings: Is a Beat in the Cards?
Fri, 22 Jan 2021 17:28:05 +0000
AmEx's (AXP) Q4 earnings results are likely to reflect a decline in overall spending but the magnitude is likely to be more moderate than its earlier quarters.

Why American Express (AXP) Might Surprise This Earnings Season
Fri, 22 Jan 2021 13:53:01 +0000
American Express (AXP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Collection Sites Announces Partnership with Health and Wellness Expert, Heidi Powell
Thu, 21 Jan 2021 12:30:00 +0000
Collection Sites and Celebrity Heidi Powell Opens Two COVID-19 Testing Centers – Gives Away Free 30-day Subscription to The Transform App and Provides Access to Innovative Fitness and Nutrition Content to Help People Strengthen and Maintain Healthy BodiesTORONTO, Jan. 21, 2021 (GLOBE NEWSWIRE) — Medivolve, Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to announce the launch of a partnership between its wholly owned subsidiary, Collection Sites, LLC, and Heidi Powell, fitness and transformation expert from ABC’s ‘Extreme Weight Loss’ show. Furthering its dedication to flatten the curve against the novel coronavirus, Collection Sites and Heidi Powell have launched two COVID-19 testing centers in Austin, Texas and Tempe, Arizona providing convenient access to rapid antibody and antigen tests. As part of the partnership, Heidi Powell has paid an upfront fee to launch the test centre in exchange for a small royalty. Through this partnership, Collection Sites customers nationwide will have access to Heidi’s suite of nutritional programs, supplements, and overall wellness resources. About the Heidi Powell Partnership Collection Sites has leased COVID-19 testing facilities in the parking lots of two shopping centers: Barton Creek Square Mall in Austin, TX and Arizona Mills in Tempe, AZ. “I am proud to serve the families in our backyard and in the Austin/Tempe areas through our connection with Collection Sites,” explains Heidi. “We hope this gesture will help to keep families safe and healthy as we all endeavor to care for one another during this challenging time.” Testing sites will now be available for those seeking fast, available, and accurate testing for themselves and their loved ones in the weeks and months ahead. The first location opened in January 2021 with daily testing capacity of 150 tests per site. Customer can use insurance or pay out-of-pocket USD between $59 to $139, depending on the test. “We are excited to see Collection Sites continue to expand its footprint, now with over 700 contracted locations secured across the United States,” says Mr. Doug Sommerville, CEO of Medivolve, Inc. “Each site offers a comprehensive COVID-19 testing solution, including insurance covered antigen, PCR, and antibody tests. By helping provide greater access to testing and making testing part of a regular shopping routine, we can help society flatten the curve.” The pop-up labs are managed by Las Vegas based company Collection Sites, LLC and powered by Alcala Testing and Analysis Services, a CLIA-licensed laboratory based in San Diego, California. Appointments and payments will be handled through an online portal: Taking The Fight A Step Further – Healthy Minds & Bodies “The fight against COVID-19 is more than just testing and a vaccine,” says Heidi. “To me, three priorities outline the path forward: control and suppress the spread of the virus; strengthen and maintain health in our bodies; and support each other to stay safe, healthy and well,” With so many organizations requiring tests for various reasons including traveling or playing sports even if individuals aren't experiencing symptoms, it became obvious that consumers were looking for easy and accurate testing options. As an authority in the health and wellness space, I feel it is my responsibility to offer a quality solution and quickly partnered with the team at Collection Sites to deliver that to consumers. Earlier this year, Heidi and Chris Powell began offering 30 days of free workouts and recipes in their exclusive Transform App Users Community on Facebook. “My mission is to support Americans’ desires to remain healthy during the pandemic and help meet their individual health and wellness needs,” says Heidi. “Through Collection Sites and Transform HQ, we're committed to helping people take control of their personal health journeys by providing them with tailored solutions that go beyond testing.” For Collection Sites customers, Heidi is graciously extending multiple offerings such as: 30-Day Free Trial to The Transform App – wellness and transformation app including: meal plans & grocery lists; macro tracking; hydration tracking; personalized daily workouts; weekly motivation; smart troubleshooting; and a built-in support system.20% Off Sitewide on Transform HQ – nutritional vitamins, supplements, energy and immune boosting products from the Wellness Line, Perform Workout Line, and Weight Loss Line.Exclusive Tips & First Access to Upcoming Virtual Health Series: Tips on How to Cope with COVID-19 Stress, How to Stay Energized at Home, How to Get Gym-based Results at Home … and more! For more information about the pop-up labs, the available sites and services, and Heidi Powell’s offerings, visit About Heidi Powell Heidi Powell is the ultimate female force. She is a trainer, transformation specialist, mother of four, savvy businesswoman, author, nutrition nut, and overall health guru. Heidi became a fixture in America’s living room as she worked side-by-side Chris Powell on ABC’s hit show, “Extreme Weight Loss”, which continues to touch lives weekly as EWL airs in syndication on TLC and OWN networks, and in 148 countries worldwide. Heidi and Chris Powell launched their debut digital platform, TRANSFORM, and the app has received over 400K downloads, has over 25K active users, providing users with the motivation, exercises, one-on-one coaching programs, nutrition, macro and hydration tracking, and built-in community for a successful health transformation. Over the years, Heidi’s portfolio has expanded to launching multiple supplement lines, co-founding female owned Athia Skin, personal development courses, blogging, best-selling book writing, appearances on national television such as “Good Morning America” and “The Dr. Oz show”, and graced the cover of several publications to date, including Oxygen Magazine and more. About the Collection Sites The pop-up labs will be managed by Las Vegas based company Collection Sites, LLC and powered by Alcala Testing and Analysis Services, a CLIA-licensed laboratory based in San Diego, California. Appointments and payments will be handled through an online portal The key to flattening the curve is to increase testing. The testing centers will offer convenient access to rapid antibody and antigen tests – which take 8-10 minutes to administer and provide results within 24 hours. The sites also offer regular RT-PCR. All tests can be administered with insurance coverage options. The tests results can be communicated via text or email and can be accompanied with a certificate of good health via a HIPAA-compliant smartphone application. For more information about the pop-up lab, the available sites and services visit About Medivolve, Inc. Medivolve, Inc. (NEO:MEDV; OTC:COPRF; FRA:4NC) seeks out disruptive technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate remarkable risk-adjusted returns for investors. Specifically, Medivolve offers investors a diversified investment in the COVID-19 medical space across three areas; prevention, detection, and treatment. Medivolve has a team of renowned global medical and business advisors that have developed a proprietary business strategy to capitalize on high-margin opportunities in the COVID-19 space. This panel includes prominent immunologist Dr. Lawrence Steinman and Dr. Glenn Copeland, who has 45 years of experience in orthopaedic treatment, foot and ankle care, and sports medicine. Medivolve’s primary focus is to provide convenient and assessable medical services for testing of the COVID-19 virus to help combat the pandemic. This is achieved largely through two acquisitions: 100% of Collection Sites, LLC and 28% of Colombian Sanaty IPS. Collection Sites is setting up a series of COVID-19 testing sites across the United States with appointments and payments will be handled through the online portal Sanaty is setting up a series of full-service medical clinics offering a complete COVID-19 testing solution. For additional information, please contact: Doug Sommerville, For investing inquiries please contact:Evan Veryard For US media enquires please contact:Veronica Cautionary Note Regarding Forward-looking Information This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the expansion of COVID-19 testing sites; the proposed roll-out of testing sites; the partnership with Heidi Powell; projected timelines for testing results; projected revenues from the testing; the pursuit by Medivolve of investment opportunities; and the merits or potential returns of any such investments. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws. NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAS REVIEWED OR ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Goldman CEO Solomon Confident in Hitting Targets, Plays Down Need for Acquisitions
Wed, 20 Jan 2021 19:08:00 +0000
Solomon said the firm isn’t interested in spinning off its Marcus consumer banking platform and that only 10% to 13% of its New York staff is working from the office.

Related Posts


MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.

This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.

The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The educational training program and software services are provided to improve financial understanding.

The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.